We are live on ! Find out more
VanEck Associates

VanEck Associates Portfolio holdings

AUM $133B
1-Year Est. Return 72.99%
This Fund
S&P 500
This Quarter Est. Return
+4.01%
1 Year Est. Return
+72.99%
3 Year Est. Return
+157.94%
5 Year Est. Return
+206.35%
10 Year Est. Return
+770.56%
AUM
$21.4B
AUM Growth
+$1.27B
Cap. Flow
+$730M
Cap. Flow %
3.41%
Top 10 Hldgs %
26.79%
Holding
881
New
137
Increased
443
Reduced
202
Closed
30

Top Buys

Rank Stock Value
1
AU icon
AngloGold Ashanti
AU
+$259M
2
VALE icon
Vale
VALE
+$83M
3
WPX
WPX Energy, Inc.
WPX
+$44.4M
4
GFI icon
Gold Fields
GFI
+$39.7M
5
RGLD icon
Royal Gold
RGLD
+$35.7M

Top Sells

Rank Stock Value
1
MON
Monsanto Co
MON
+$109M
2
NEM icon
Newmont
NEM
+$96M
3
B
Barrick Mining
B
+$77.1M
4
FNV icon
Franco-Nevada
FNV
+$63.2M
5
GG
Goldcorp Inc
GG
+$58M

Sector Composition

Rank Sector Weight
1 Materials 50.75%
2 Energy 16.94%
3 Healthcare 6.45%
4 Technology 5.96%
5 Consumer Staples 2.71%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MON
876
DELISTED
Monsanto Co
MON
-933,324
Closed -$109M
AHGP
877
DELISTED
Alliance Holdings GP
AHGP
-107,650
Closed -$2.69M
MSCC
878
DELISTED
Microsemi Corp
MSCC
-267,700
Closed -$17.3M
ANTX
879
DELISTED
Anthem, Inc.
ANTX
-242,444
Closed -$13M
APLP
880
DELISTED
Archrock Partners, L.P. Common Units representing Limited Partner Interests
APLP
-219,248
Closed -$2.68M
FMSA
881
DELISTED
Fairmount Santrol Holdings Inc.
FMSA
-3,850,649
Closed -$16.4M

Similar funds

VanEck Associates's Q2 2018 Portfolio in Review

As of Q2 2018, VanEck Associates held 881 positions worth $21.4B, up 6.3% from $20.1B the previous quarter. Its ten largest holdings account for 27% of the portfolio.

VanEck Associates deployed $730M of net new capital in Q2 2018, opening 137 new positions and adding to 443 existing holdings. Its largest new stake was Colgate-Palmolive: 345,613 shares worth $22.4M.

By sector, the portfolio is most concentrated in Materials at 51% of assets, down from 52% a quarter earlier, followed by Energy and Healthcare.

On the sell side, the largest reduction was Newmont, an estimated $96M trimmed.

  • VanEck Associates's largest Q2 2018 buy was Colgate-Palmolive: 345,613 shares worth $22.4M.
  • VanEck Associates added most to AngloGold Ashanti in Q2 2018, an estimated $259M increase.
  • VanEck Associates's biggest Q2 2018 reduction was Newmont, cutting an estimated $96M.
  • VanEck Associates fully exited Monsanto Co in Q2 2018, selling an estimated $109M.
  • VanEck Associates's ten largest holdings make up 27% of its $21.4B portfolio in Q2 2018.
  • VanEck Associates opened 137 new positions and closed 30 in Q2 2018.
  • VanEck Associates's portfolio value rose 6.3% quarter-over-quarter to $21.4B.

Based on VanEck Associates's 13F filing for Q2 2018, filed 13 Aug 2018.